Followers | 839 |
Posts | 120719 |
Boards Moderated | 13 |
Alias Born | 09/05/2002 |
Thursday, August 29, 2019 10:45:49 AM
https://finance.yahoo.com/news/abbvie-discontinues-rovalpituzumab-tesirine-rova-124500700.html
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABBV News
- AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia • PR Newswire (US) • 11/11/2024 01:30:00 PM
- Allergan Aesthetics Celebrates Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day • PR Newswire (US) • 11/07/2024 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/04/2024 09:16:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/04/2024 09:15:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 07:19:33 PM
- Amazon Up 6%, Atlassian Jumps 20%; Intel Posts Surprising Profit; Abbott Wins Infant Formula Lawsuit • IH Market News • 11/01/2024 10:55:39 AM
- AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics • GlobeNewswire Inc. • 10/31/2024 12:00:08 PM
- AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics • PR Newswire (US) • 10/31/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 11:43:14 AM
- AbbVie Reports Third-Quarter 2024 Financial Results • PR Newswire (US) • 10/30/2024 11:38:00 AM
- AbbVie's VRAYLAR® (cariprazine) Now Publicly Reimbursed in Ontario • PR Newswire (Canada) • 10/29/2024 12:00:00 PM
- SkinSpirit joins Allergan Aesthetics in Supporting Girls Inc. and Empowering the New Generation of Women in STEM • PR Newswire (US) • 10/29/2024 12:00:00 PM
- AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline • PR Newswire (US) • 10/28/2024 12:00:00 PM
- AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions • PR Newswire (US) • 10/24/2024 03:30:00 PM
- Nine Provinces Approve Accelerated Public Reimbursement of Diffuse Large B-Cell Lymphoma Treatment Under New Early Access Process • PR Newswire (Canada) • 10/21/2024 12:00:00 PM
- Neuf provinces approuvent le remboursement accéléré par le régime public d'un traitement contre le lymphome diffus à grandes cellules B, en vertu d'un nouveau processus d'accès rapide • PR Newswire (Canada) • 10/21/2024 12:00:00 PM
- BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands) • PR Newswire (US) • 10/18/2024 11:44:00 PM
- U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease • PR Newswire (US) • 10/17/2024 12:00:00 PM
- Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight into Patient Perception • PR Newswire (US) • 10/16/2024 12:00:00 PM
- Allergan Aesthetics and Girls Inc. Celebrate Six Years and Challenge You to Take the Pledge to Support Mentorship in STEM • PR Newswire (US) • 10/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:07:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 09:00:11 PM
- Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • InvestorsHub NewsWire • 10/02/2024 01:00:00 PM
- Available Nationwide: JUVÉDERM® VOLUMA® XC for Moderate to Severe Temple Hollowing • PR Newswire (US) • 10/02/2024 12:00:00 PM
- AbbVie to Host Third-Quarter 2024 Earnings Conference Call • PR Newswire (US) • 10/01/2024 12:00:00 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM